Remove Licensing Remove Marketing Remove Targeted Protein Degradation
article thumbnail

Biotech Risk Cycles: Assets And Platforms

LifeSciVC

Today’s market likes products. Investors, especially in the public markets, only want late stage de-risked assets. Or so the conventional wisdom goes in the equity capital markets these days. The tone of today’s market reveals it’s close to suffering those latter conditions. Platforms aren’t in vogue anymore.